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ABSTRACT 
 
New antimalarial treatments are now urgently required, following the emergence of resistance 
to the most used drugs. Natural products contribute greatly to the therapeutic arsenal in this 
area, including artemisinin, quinine (and atovaquone, semi-synthetic). Among the natural 
products, indole alkaloids represent an interesting class of compounds. Screening carried out 
to date has revealed several substances active in vitro under the µM range and with a good 
selectivity index. This review covers the indole alkaloids with high antiplasmodial activity (in 
vitro, in vivo) isolated from natural sources and is organized according to the different 





Plasmodium falciparum, Plasmodium berghei, antiplasmodial, malaria, indole alkaloid, 
natural products. 
Malaria is the major parasitic infection in many tropical and subtropical regions, leading to 
more than one million deaths out of 400-500 million cases each year (WHO, 2005). 
Discovering new drugs in this field is therefore a health priority. The challenge in malaria 
chemotherapy is to find safe and selective agents whose potency will not be compromised by 
plasmodial resistance. In this context, the search for antiprotozoal compounds from terrestrial 
plants and marine organisms could provide new leads to antimalarial drugs.  The natural 
active principles are detected either after bioguided isolation from species with a reputation 
for use in traditional medicine or after a screening campaign involving in vitro or in vivo 
bioassay procedures. The topic of new antimalarial drugs from traditional medicines has been 
largely reviewed these last years (Willcox and Bodeker, 2004; Bourdy et al., 2007). 
 
In this review, we will focus on indole alkaloids that show antiplasmodial properties. The 
alkaloids are a phytochemical class known to possess antiplasmodial properties, the most 
famous being quinine, which is a quinoleic alkaloid but whose biosynthetic pathway is 
common to indolomonoterpenoid alkaloids (the most important class of indole alkaloids).  
 
In order to compare all compounds, we will use the 50% inhibitory concentration (IC50) and, 
when available, the selectivity index (SI), which is defined as the ratio of cytotoxicity over 
antiplasmodial activity, each one expressed with IC50. Table 1 summarizes the IC50 and SI of 
the most important compounds described in this manuscript. Several plasmodial strains were 
used to assess the activity of the compounds described below. We have chosen to classify 
them into "chloroquine-sensitive", CQS, and "chloroquine-resistant", CQR, strains.  
 
1. Indole analogues from emetine 
 
The first studies dealing with the antiplasmodial activity of indole alkaloids were initiated in 
England more than 20 years ago. The aim of those studies was to compare the amoebicide 
activity of emetine (1) with indolic natural analogues such as tubulosine (2) (Figure 1). Some 
of these analogues were active, but at concentrations much higher than emetine (1) and 
without selectivity compared to human cells (Keene et al., 1983; Keene et al., 1987). The in 
vitro screening was then extended to other indolic analogues of emetine, which have been 
previously isolated in the laboratory of pharmacognosy at the University of Liège (Belgium), 
and other protozoa were included in the screening, especially Plasmodium falciparum. This 
time, some indolic alkaloids were shown to be very active against P. falciparum, such as 
strychnopentamine (3) (IC50 = 150 nM) and dihydrousambarensine (6) (IC50 = 23 nM) (Figure 
2). This last alkaloid was nevertheless seen to be inactive in vivo (at the dose of 30 mg/kg per 
os or subcutaneously) in mice infected with Plasmodium berghei (Wright et al., 1991). Other 
indole alkaloids from various plant species from the genus Strychnos were then evaluated (S. 
usambarensis, S. variabilis and S. henningsii). In this study, only strychnobiline from S. 
variabilis and dihydroflavopereirine from S. usambrensis presented a slight activity (IC50 near 
1 µM) (Wright et al., 1994). The most interesting alkaloids were still the usambarensine (5) 
derivatives from S. usambarensis (Figure 2). Investigations concerning these alkaloids were 
then continued in Liège and showed that dihydrousambarensine was much more active 
against chloroquine-resistant strains (IC50 = 32 nM and SI of 375) than against chloroquine-
sensitive ones (IC50 = 857 nM and SI of 14). This observation could explain the failure of in 
vivo experiments conducted on a chloroquine sensitive strain of P. berghei (Frederich et al., 
1999a). Afterwards, it was shown that strychnopentamine (3) and isostrychnopentamine (4) 
were active with the same IC50 against all strains of P. falciparum (IC50 = 120 nM and SI = 
60) (Frederich et al., 1999a) and at all stages of development, including rings (Frederich et al., 
2004b). Isostrychnopentamine (4) was also active in vivo with an ED50 of 30 mg/kg (i.p., P. 
berghei and P. vinckei petteri) (Frederich et al., 2004b). 
 
In the continuation of this paragraph dedicated to the indole analogues of emetine, we will 
cite a study published in 1996 and devoted to Pogonopus tubulosus (Sauvain et al., 1996). 
This tree from South-America is used traditionally in Bolivia against malaria (decoction of 
stem bark) and is called "falsa quina". A bioguided fractionation attributed the antiplasmodial 
properties to the alkaloidal fraction and mainly to tubulosine (2), already cited previously. 
Tubulosine is active against all strains of P. falciparum (IC50 = 24 nM) but has no selectivity 
compared to human cells. Active in vivo (ED50 = 1 mg/kg), there was also shown to be a high 
level of toxicity (all mice died following a dose of 2 mg/kg). 
 
2. Other bisindole alkaloids from Strychnos species 
 
As some bisindole alkaloids from Strychnos species showed some promising activity, our 
team in Liège continued to screen several of these species and various alkaloids isolated from 
these plants (Frederich et al., 1999b; Frederich et al., 1999a; Frederich et al., 2002; Frederich 
et al., 2004a; Philippe et al., 2005). Among the Strychnos species investigated, S. icaja was 
particularly interesting. The monoindole alkaloids known in this plant were deprived of any 
significant antiplasmodial activity. Bioguided fractionation led to the isolation of several 
oxygenated bisindole alkaloids, derivatives of sungucine (7), which were responsible for the 
activity of the plant (Frederich et al., 2000; Frederich et al., 2001a) (Figure 3). The most 
active compounds were isosungucine (8) (IC50 = 168 nM - CQR), 18-hydroxy-isosungucine 
(9) (IC50 = 85 nM - CQR)  and strychnogucine B (10) (IC50 = 85 nM -CQR)  with, for the last 
one, an SI of 176 (W2-CQR). These compounds were clearly more active against CQR than 
against CQS strains. Isosungucine, isolated in higher quantities than the two other compounds 
was evaluated in vivo and showed an ED50 of close to 30 mg/kg (i.p., mice, P. vinckei petteri 
(Philippe et al., 2007). It was also shown that these bisindole alkaloids, structurally related to 
strychnine, were deprived of their strychnine-like convulsivant activity (Philippe et al., 2006). 
The underlining of the antimalarial activity of "isosungucine" alkaloids could explain the 
traditional use of Strychnos icaja by the Pygmies from Cameroon to treat malaria fevers. 
Nevertheless, further studies will be necessary to confirm the interest of these alkaloids for 
human medicine. 
 
Thanks to collaboration with the pharmacognosy department from the University of Reims 
(France), other bisindole alkaloids were also evaluated. Of the more than 50 alkaloids tested, 
only three were of some interest: ochrolifuanine A (11), matopensine and longicaudatine (12), 
but all three were shown to be less active than isostrychnopentamine or strychnogucine B 
(Figure 3) (Frederich et al., 2002). 
 
3. Other bisindole alkaloids from seed plants 
 
Several Alstonia species (Apocynaceae) are traditionally used in Africa for their antimalarial 
properties (Wright et al., 1993). Several species (especially Alstonia scholaris, A. 
macrophylla and A. glaucescens) were investigated and their antimalarial properties were 
attributed to bisindole alkaloids, notably villalstonine (13, Figure 4) and macrocarpamine, 
(14), which possess, respectively, IC50s of 270 nM and 360 nM against a CQR strain of P. 
falciparum (Keawpradub et al., 1999). 
 
Tabernaemontana fuchsiaefolia A. DC. (synonym: Peschiera fuchsiaefolia (DC) Miers) is 
again a tree from the family Apocynaceae known in Brazil by the name "leiteira" because of  
the presence of latex in the plant. This species is currently used in traditional medicine to treat 
malaria in Sao Paulo and Parana states (Zocoler et al., 2005). The activity was attributed again 
to bisindole alkaloids, the principal one being voacamine (15, Figure 4) (IC50 = 411 nM, SI = 
47 on CQR strain) (Federici et al., 2000). Voacamine is active in vivo (43% of reduction of 
parasitaemia at 10 mg/kg p.o. in the 4-day suppressive test of Peters) and presents some 
specificity for trophozoites and schizonts (Ramanitrahasimbola et al., 2001). 
 
A phytotherapeutic preparation containing Peschiera fuchsiaefolia extracts is used in 13 
African countries and in the Dominican Republic under the registered names MMH Malarex® 
and MMH 18®. The company Millenia Hope claims to have carried out clinical trials, but the 
absence of scientific publications aroused questions from the scientific community about the 
efficacy and the exact composition of this preparation (Martindale, 2002; Orellana, 2003). 
 
4. Semi-synthetic bisindole and trisindole 
 
To the best of our knowledge, the only indole semi-synthetic antiplasmodial compounds 
known to date are derivatives of ergolines, which are either natural compounds isolated from 
Claviceps purpurea (festuclavine…) or semi-synthetic compounds used in clinical routine 
(terguride…) (Figure 5). After the detection of a slight antiplasmodial activity for some 
monomeric ergolines, a German team tried to investigate semi-synthetic dimeric or 
oligomeric derivatives of these ergolines linked by a central benzenic bond. Only two 
derivatives were of interest: a dimeric derivative of terguride (17) (IC50 = 540 nM, SI = 47, 
CQR) and a trimeric derivative of festuclavine (16) (IC50 = 540 nM, SI = 185, CQR). 
Nevertheless, these compounds, administered to mice, induced behavioural modifications, 




It is impossible to write about indolic alkaloids and malaria without mentioning cryptolepine, 
isolated from Cryptolepis sanguinolenta. Cryptolepine (18, Figure 6) is an indole alkaloid, but 
not from indolomonoterpenic biosynthetic pathways. This alkaloid, initially known as 
synthetic (synthesis in 1906 (Fichter & Boehringer, 1906)), was then isolated from roots of C. 
sanguinolenta, previously known as C. triangularis, (Asclepiadaceae) in 1929 (Clinquart, 
1929). Cryptolepine was then isolated from Sida acuta (Malvaceae) and from Microphilis 
guianensis (Gunatilaka et al., 1980; Yang et al., 1999). 
 
Cryptolepis sanguinolenta is a plant frequently used as an antimalarial, antidysentery and 
febrifuge remedy in Central and Western Africa. Between 1995 and 1997, three independent 
teams evidenced the antiplasmodial properties of cryptolepine in vitro (IC50 = 114 nM, SI = 9, 
CQR) and in vivo (mice, ED50 < 50 mg/kg p.o. and DE50 = 10 mg/kg i.p.) (Cimanga et al., 
1997; Grellier et al., 1996; Kirby et al., 1995; Wright et al., 1996). Recently, it has been 
shown that cryptolepine and derivatives are able to inhibit hemozoin polymerization 
(Onyeibor et al., 2005). 
 
Several semi-synthetic derivatives have been synthesized. The most interesting are: 
 
- 2,7-dibromocryptolepine (IC50 = 49 nM, CQR), active against Plasmodium berghei in mice 
(90% of suppression of parasitaemia at 12.5 mg/kg i.p.) (Onyeibor et al., 2005; Wright et al., 
2001);  
- 1-methyl-δ-carboline (21), anhydronium base with an IC50 of 1.5 µM and an SI of higher 
than 100 (Arzel et al., 2001);  
- 2-bromoneocryptolepine, less active than cryptolepine (IC50 = 4 µM), but which also 
presents less affinity towards DNA. Neocryptolepine (19) is a natural alkaloid from the genus 
Cryptolepis (Jonckers et al., 2002; Van Miert et al., 2004); 
- Isoneocryptolepine (20), synthetic, (IC50 = 40 nM) and N-methyl-isocryptolepinium iodide 
(23) (CI50 = 17 nM), these two compounds presenting a much smaller cytotoxicity than 
cryptolepine. Nevertheless, they were found to be unusable in vivo (mice, s.c., 50 mg/kg, P. 
berghei), the quaternary compound being highly toxic, in spite of an impressive SI of >700 
(toxicity probably due to curarizing activity) (Van Miert et al., 2005). 
 
Other teams have also shown that cryptolepine presents high level of cytotoxic, genotoxic, 
DNA intercaling, topo II inhibition properties (Ansah et al., 2005; Ansah & Gooderham, 
2002; Bonjean et al., 1998; Lisgarten et al., 2002). Further studies are therefore needed prior 
to the development of an antimalarial drug from this family. 
 
6. Tryptanthrin derivatives  
 
Tryptanthrin (24, Figure 7) is an indoloquinazolin well known to possess antimicrobial 
properties against several bacterial strains, including Mycobacterium tuberculosis. Firstly 
isolated from tryptophane enriched Candida lypolytica cultures (Schindler & Zahner, 1971), 
tryptanthrin has been subsequently isolated from several higher plants: Couroupita guianensis 
from Amazonia, Isatis tinctoria, Polygonum tinctorium, Strobilanthes cusia and Wrightia 
tinctoria (George et al., 1996; Hamburger, 2002; Ho et al., 2003; Honda et al., 1980; Iwaki et 
al., 2005; Muruganandam et al., 2000).  
 
It was the Walter Reed Research Institute from the USA that tested thryptanthrin, firstly 
against Leishmania sp., then against Plasmodium falciparum. Tryptanthrin and several 
analogues were tested and showed very low IC50 values: 69 ng/ml for thryptanthrin and 0.43 
to 10 ng/ml for some of the analogues. These compounds were particularly active against 
atovaquone, chloroquine or mefloquine resistant strains. Novel tryptanthrin compounds, 
possessing increased solubility, have been recently prepared in order to carry out in vivo 
testing (Bhattacharjee et al., 2004; Nichols et al., 2003). These results are impatiently awaited. 
It is also interesting to note that tryptanthrin also possesses immunostimulating properties, 
which could be useful in the fight against malaria (Valiante, 2004). 
 
7. Marine sources 
 
Several 1-aminopolycyclic β-carbolin alkaloids isolated from marine sources possess high in 
vitro and in vivo antimalarial properties (Ang et al., 2000; Rao et al., 2003; Rao et al., 2004). 
The most active alkaloids are manzamine A (IC50 = 4.5 - 8 ng/ml, CQS and CQR) (25, Figure 
7) and manzamine B, initially discovered in sponges from Manzamo (Okinawa, Japan). But, 
in fact, manzamines appear to be synthesized by actinomycetes (Micromonospora), symbiotic 
with these sponges (Hill et al., 2006). 
 
Administered to mice at a dose of 55 mg/kg, i.p., manzamine A induces a reduction of 
parasitaemia of 96% (versus 99% for chloroquine and 57% for artemisinin). The relative 
inefficacy of artemisinin in this assay could be explained by its short half-life. An effective 
treatment with artemisinin requires several daily administrations. The survival of mice is also 
increased by up to 60 days and manzamine A has also been shown to be active via the oral 
route. The development of these compounds was supported by "Medicine for Malaria 
Venture" (http://www.mmv.org), but the support was stopped in 2005 following serious 
worries concerning the toxicological profile of the compound. Effectively, in vivo toxicity 




8. Chloroquine potentialization 
 
The development of chloroquine resistance in Madagascar during the 1980s led to the 
widespread use of traditional medicines, and a very particular use of some plants appeared: 
rasped stems of Strychnos myrtoides, S. diplotricha and S. mostueoides were used in 
decoctions associated to a sub-therapeutic dose of chloroquine (100-200 mg) (Rasoanaivo et 
al., 1996b; Rasoanaivo et al., 2002; Rasoanaivo et al., 2005). Phytochemical investigations of 
these species led to the isolation of two bioactive alkaloids: strychnobrasiline (26, Figure 8) 
and malagashanine (27) (Caira & Rasoanaivo, 1995; Rasoanaivo et al., 1994; Rasoanaivo et 
al., 1996a).  
 
These two alkaloids are very weak antiplasmodial compounds (IC50 around 100 µM), but, 
associated to chloroquine, they are able to reverse the in vitro resistance of P. falciparum to 
this drug (Rasoanaivo et al., 1994). Malagashanine is also active in vivo in mice contaminated 
by P. yoeleii, but there, strychnobrasiline is completely inactive. Authors attribute this 
discrepancy to a difference in solubility, malagashanine being less hydrophilic. 
Malagashanine is also able to reverse the resistance to quinine, mefloquine, halofantrine, 
quinacrine and pyronaridine (Rafatro et al., 2000a). A very small clinical study has also been 
conducted in Antananarivo (20 patients, chloroquine + 500 mg stem bark S. myrtoides) and 
showed promising results (Ramialiharisoa et al., 1994). Nevertheless, other studies following 
WHO guideline are required in order to confirm the interest of this association.  
 
The mode of action of malagashanine has been recently described as a stimulation of the 
chloroquine influx towards resistant Plasmodium and a diminution of the efflux from the  
inside (Ramanitrahasimbola et al., 2006). Metabolization of malagashanine has also been  
studied, on human microsomes and rats (Rafatro et al., 2000b; Rafatro et al., 2000c) and 
toxicity studies have been conducted on guinea pigs: malagashanine appears as not cytotoxic 
and without cardiac toxicity (either alone or associated to chloroquine). Some simplified 
analogues of malagashanine have also been recently synthesized and are active in vitro 
(Chouteau et al., 2005). 
 
At the university of Liège, icajine (Figure 8, 28) and isoretuline (29), alkaloids presenting 
some analogies to strychnobrasiline and malagashanine have also been shown to be 
chloroquine and mefloquine resistance reversal agents (Frederich et al., 2001b). A 
chloroquine potentiating effect was also demonstrated for N-formyl-aspidospermidine (30) 





Among the natural products, indole alkaloids represent an interesting class of compounds. 
Screening carried out to date has revealed several substances active in vitro under the µM 
range and with a good selectivity index. Nevertheless, in vivo activity has been confirmed 
only in a small number of cases, and there is a need to undertake research focused on the 
mode of action of these compounds. 
 
Antiplasmodial indole alkaloids can be separated into three main  categories.  
 
The first category contains the alkaloids with a molecular weight of higher than 400 and a 
quite important steric crowding:  
-indole "analogues" of emetine (usambarensine, ochrolifuanine, strychnopentamine), 
-other bisindole alkaloids such as voacamine, ergoline derivatives, matopensines and 
isosungucines.  
 
Several of these alkaloids have been shown to be much more active against chloroquine-
resistant strains. This phenomenon deserves to be elucidated. 
 
Considering the complexity of this groups of compounds, very few attempts have been made 
to modify them chemically, as has been the case (in cancer therapy) for Vinca alkaloids. This 
approach could nevertheless be very interesting. 
 
The second category contains insaturated monomeric heterocycles. These are chemically 
much more attainable. There are two main models that have been developed: 
- derivatives of cryptolepine (the most interesting compound being 2,7-
dibromocryptolepine); 
- derivatives of tryptanthrin. 
 
Considering this last group, there is still a lot of investigation needed concerning their in vivo 
potentiality.  
 
Finally, the last group of interesting indolic compounds includes monoindole alkaloids able to 
reverse the resistance to chloroquine. Among these, the most interesting compound seems to 
be malagashanine, found in Strychnos myrtoides from Madagascar. This compound is active 
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Table 1: Antiplasmodial IC50 of various indole alkaloids and selectivity index (SI), if available. CQR =  chloroquine 




IC50 (µM) SI Strain Resistance 
quinine 0.413 ND W2 CQR 
dihydrousambarensine 0.032 375 W2 CQR 
isostrychnopentamine 0.152 49 W2 CQR 
strychnogucine B 0.085 176 W2 CQR 
tubulosine 0.024 0.9 INDO CQR 
voacamine 0.411 47 W2 CQR 
villalstonine 0.270 18 K1 CQR 
macrocarpamine 0.360 13 K1 CQR 
cryptolepine 0.114 9 K1 CQR 
neocryptolepine 2.610 1.2 K1 CQR 
isoneocryptolepine 0.230 19 K1 CQR 
N-methyl-isocryptolepinium 0.017 747 K1 CQR 
2-bromoneocryptolepine 4.0 > 8 W2 CQR 
2,7-dibromocryptolepine 0.049 122 K1 CQR 
1-methyl-delta-carboline 1.5 > 100 K1 CQR 
thryptantrine 0.278 - W2 CQR 
manzamine A 0.956 - W2 CQR 
dimeric derivative of terguride  
("p-xylene linked") 
0.54  46 Dd2 CQR - MQR 




FIGURE 1: Chemical structures of compounds 1-2. 
FIGURE 2: Chemical structures of compounds 3-6. The circle indicate the isomery in 
isostrychnopentamine. 
FIGURE 3: Chemical structures of compounds 7-12. The circles indicate the isomery between 
sungucine and isosungucine. 
FIGURE 4: Chemical structures of compounds 13-15. 
FIGURE 5: Chemical structures of compounds 16-17. 
FIGURE 6: Chemical structures of compounds 18-23. 
FIGURE 7: Chemical structures of compounds 24-25. 
FIGURE 8: Chemical structures of compounds 26-31. 
Fig. 1 
 
      
 






















    





         
 





































































Sungucine (7)   Isosungucine (8)  18-Hydroxyisosungucine (9) 
  
 










































































       
 








































































Trimeric derivative of Festuclavine (16)  Dimeric derivative of Terguride (17) 
Fig. 6 
 
        
 
Cryptolepine (18)                            Neocryptolepine (19) Isoneocryptolepine (20) 
 
                            
 
N1-Methyl-δ-carboline (21)  R=H   Isocryptolepine (22)                 
























               
 
































     
 




           
 















N-formyl-aspidospermidine (30) Aspidospermine (31) 
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